Zoetis receives FDA approval for Convenia RTU for Dogs, helping more medium and large dogs access single-injection treatment
EN
eFeedLink Newsdesk
The more concentrated cefovecin formulation provides up to 14 days of antibiotic treatment for bacterial skin infections in one injection, with launch expected in Q1 2027.
Related Articles
US FDA places 11 foreign seafood firms on import alert over ice glaze short-weighting
29 Oct 2026
Approvals widen for PIC's PRRS-resistant pig, but herd build-up will take years
7 Oct 2026
FDA releases in-country assessment report on cesium-137 import certification for Indonesia's shrimp and spice products
6 Oct 2026